Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Poly ICLC + Pooled Mutant KRAS-Targeted Long Peptide Vaccine |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Poly ICLC | Hiltonol | Hiltonol (poly ICLC) is a synthetic double stranded RNA complex, which induces interferon production and stimulates anti-tumor immune response (PMID: 22126373). | ||
Pooled Mutant KRAS-Targeted Long Peptide Vaccine | KRAS Peptide Vaccine | KRAS Inhibitor 18 | Pooled mutant KRAS-targeted long peptide vaccine is a mixture of long tumor-specific mutant KRAS peptides, which potentially induces a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing KRAS (NCI Drug Dictionary, Cancer Res (2023) 83 (8_Supplement): CT036). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|